Peter G. Hartman
From Wikipedia, the free encyclopedia
Peter George Hartman (* 1947 in Brno, former Czechoslovakia) is an English-German biochemist who made fundamental contributions in the field of pharmaceutical research to chemotherapy. He was also involved in the EU Biofector project as a team member.[1]
Hartman grew up in the UK and attended school in Portsmouth. He then went on to study natural sciences with a focus on chemistry at Merton College in Oxford with an MA and then a research stay at the Polytechnic University in Portsmouth. With the dissertation: The Structure of the Lysine-Rich Histone H1: an NMR Study Hartman received his PhD.
This was followed by stays as a postdoc at the Max Planck Institute in Tübingen and in the Biozentrum of the University of Basel. His 25 years of research at F. Hofmann-La Roche in Basel on anti-fungal and ant-bacterial chemotherapy, cardiovascular diseases and diabetes led to current forms of therapy. Since his retirement, he has made his experience and specialist language knowledge available as a translator of specialist publications in EU projects.
Peter Hartman lives with his wife Brigitte in Lörrach (Germany)
